- Home
- TENX vs CRIS Comparison
TENX vs CRIS Comparison
Compare TENX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- CRIS
- Stock Information
- Founded
- TENX 1967
- CRIS 2000
- Country
- TENX United States
- CRIS United States
- Employees
- TENX N/A
- CRIS N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TENX Health Care
- CRIS Health Care
- Exchange
- TENX Nasdaq
- CRIS Nasdaq
- Market Cap
- TENX 21.6M
- CRIS 21.3M
- IPO Year
- TENX N/A
- CRIS 2000
- Fundamental
- Price
- TENX $6.17
- CRIS $2.28
- Analyst Decision
- TENX Strong Buy
- CRIS Strong Buy
- Analyst Count
- TENX 3
- CRIS 2
- Target Price
- TENX $16.00
- CRIS $16.50
- AVG Volume (30 Days)
- TENX 35.4K
- CRIS 75.5K
- Earning Date
- TENX 08-12-2025
- CRIS 07-31-2025
- Dividend Yield
- TENX N/A
- CRIS N/A
- EPS Growth
- TENX N/A
- CRIS N/A
- EPS
- TENX N/A
- CRIS N/A
- Revenue
- TENX N/A
- CRIS $11,202,000.00
- Revenue This Year
- TENX N/A
- CRIS N/A
- Revenue Next Year
- TENX N/A
- CRIS $10.67
- P/E Ratio
- TENX N/A
- CRIS N/A
- Revenue Growth
- TENX N/A
- CRIS 14.17
- 52 Week Low
- TENX $2.80
- CRIS $1.02
- 52 Week High
- TENX $7.89
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- TENX 51.83
- CRIS 50.37
- Support Level
- TENX $5.62
- CRIS $2.11
- Resistance Level
- TENX $6.35
- CRIS $2.26
- Average True Range (ATR)
- TENX 0.46
- CRIS 0.20
- MACD
- TENX 0.01
- CRIS -0.04
- Stochastic Oscillator
- TENX 41.49
- CRIS 16.85
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.